Rigel to Participate in Upcoming September Investor Conferences [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
focused on hematologic disorders and cancer, today announced that Dean Schorno , the company's chief financial officer, will participate in the following investor conferences in September: 2024 Wells Fargo Healthcare Conference, Boston, MA Mr. Schorno will participate in one-on-one meetings on Thursday, September 5th H.C. Wainwright 26 th Annual Global Investment Conference, New York, NY Mr. Schorno will participate in one-on-one meetings and present a company overview on Tuesday, September 10th at 11:30 a.m . ET. To access the live webcast or archived recording of the H.C. Wainwright Conference presentation, visit the Investor Relations section of the company's website at www.rigel.com . Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads. About Rigel Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the liv
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- BPMC Q4 Earnings and Sales Miss Estimates, Shares Decline [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.MarketBeat
- Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell DiseasePR Newswire
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.MarketBeat
- Rigel Pharmaceuticals sets 2025 sales outlook above estimates [Seeking Alpha]Seeking Alpha
RIGL
Earnings
- 11/7/24 - Beat
RIGL
Sec Filings
- 2/14/25 - Form SCHEDULE
- 2/11/25 - Form SCHEDULE
- 2/7/25 - Form SCHEDULE
- RIGL's page on the SEC website